comparemela.com

Latest Breaking News On - Cell therapeutics - Page 9 : comparemela.com

Researchers uncover underlying mechanism driving membranous nephropathy, a chronic kidney disease in children

Researchers uncover underlying mechanism driving membranous nephropathy, a chronic kidney disease in children
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Qi-zhang
Los-angeles
Laura-perin
Professor-of-research-urology
Laboratory-for-organ-regenerative-research
Urology-research
Keck-school-of-medicine
Stefano-da-sacco
Hospital-los
Hospital-los-angeles
Organ-regenerative-research
Cell-therapeutics

CHLA Researchers Uncover Underlying Mechanism Driving Membranous Nephropathy, Offering Insights Into Chronic Kidney Disease in Children

Head to Head Comparison: BriaCell Therapeutics (OTCMKTS:BCTXF) and Eterna Therapeutics (NASDAQ:ERNA)

BriaCell Therapeutics (OTCMKTS:BCTXF – Get Free Report) and Eterna Therapeutics (NASDAQ:ERNA – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Volatility & Risk BriaCell Therapeutics has a […]

Cambridge
Cambridgeshire
United-kingdom
Massachusetts
United-states
Canada
Vancouver
British-columbia
Charlesl-wiseman
Isaacb-maresky
Eterna-therapeutics-inc

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

CARLSBAD, Calif., April 01, 2024 Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development. Dr. Hubbert has an extensive background in cell therapy research and venture investment across a broad range of therapeutic modalities and development stages, and has a

University-of-washington
Washington
United-states
American
Brianm-culley
Charlotte-hubbert
Corporate-development
University-of-washington-innovation-roundtable
Accelerator-corporation
Exchange-commission
Head-of-gates-foundation-venture-capital
Melinda-gates-foundation-strategic-investment-fund

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large Decline in Short Interest

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Sees Large Decline in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Topco-ltd
Renaissance-technologies
Nasdaq
Brainstorm-cell-therapeutics-inc
Tower-research-capital
Brainstorm-cell-therapeutics
Get-free-report
Cell-therapeutics
Research-capital
Street-group
Cell-therapeutics-inc
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.